Literature DB >> 12809493

Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis.

Thomas Welss1, Jiuru Sun, James A Irving, Rainer Blum, A Ian Smith, James C Whisstock, Robert N Pike, Anna von Mikecz, Thomas Ruzicka, Phillip I Bird, Harry F Abts.   

Abstract

Hurpin (headpin/PI13/serpinB13) is an intracellular, differentially spliced member of the serpin superfamily that has been linked to differentiation and apoptosis of human keratinocytes. It is transiently downregulated by UV light and overexpressed in psoriatic skin lesions. Although it has all of the features of an inhibitory serpin, a productive interaction between hurpin and a proteinase has not yet been reported. Here we demonstrate that hurpin is a potent and selective inhibitor of the archetypal lysosomal cysteine proteinase cathepsin L (catL). Recombinant hurpin inhibits human catL with a stoichiometry of inhibition (SI) of 1.7 and a rate constant k(assoc) of (4.6 +/- 0.14) x 10(5) M(-1) s(-1). It inefficiently inhibits catV and does not inhibit papain, catB, or catK. To investigate the inhibitory mechanism, we determined the P1-P1' bond in the reactive center loop cleaved by catL ((356)Thr-(357)Ser) and expressed variants in which the proximal hinge, P1 residue, or differentially spliced CD loop was mutated. The results of assays using these proteins suggest that inhibition of catL by hurpin occurs via the conventional serpin inhibitory mechanism and that the CD loop plays no role in the process. Finally, it was found that the majority of hurpin is cytosolic and that its overexpression in human keratinocytes confers resistance to UV-induced apoptosis. Given that lysosomal disruption, release of catL, and catL-mediated caspase activation are known to occur in response to cellular stress, we propose that a physiological role of hurpin is to protect epithelial cells from ectopic catL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809493     DOI: 10.1021/bi027307q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

Review 1.  Protease signalling: the cutting edge.

Authors:  Boris Turk; Dušan Turk; Vito Turk
Journal:  EMBO J       Date:  2012-02-24       Impact factor: 11.598

2.  Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes.

Authors:  Jan Czyzyk; Octavian Henegariu; Paula Preston-Hurlburt; Raman Baldzizhar; Christine Fedorchuk; Enric Esplugues; Kim Bottomly; Frans K Gorus; Kevan Herold; Richard A Flavell
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

3.  Multiple domains of endopin 2A for serpin cross-class inhibition of papain.

Authors:  Shin-Rong Hwang; Vivian Y H Hook
Journal:  Arch Biochem Biophys       Date:  2007-03-21       Impact factor: 4.013

Review 4.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

5.  Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium.

Authors:  Xiaoling Zhang; Paola Sebastiani; Gang Liu; Frank Schembri; Xiaohui Zhang; Yves Martine Dumas; Erika M Langer; Yuriy Alekseyev; George T O'Connor; Daniel R Brooks; Marc E Lenburg; Avrum Spira
Journal:  Physiol Genomics       Date:  2009-12-01       Impact factor: 3.107

6.  SERPINB13 is a novel RUNX1 target gene.

Authors:  Anita Boyapati; Bing Ren; Dong-Er Zhang
Journal:  Biochem Biophys Res Commun       Date:  2011-06-23       Impact factor: 3.575

Review 7.  Proteolytic networks in cancer.

Authors:  Steven D Mason; Johanna A Joyce
Journal:  Trends Cell Biol       Date:  2011-01-12       Impact factor: 20.808

8.  Heparin enhances serpin inhibition of the cysteine protease cathepsin L.

Authors:  Wayne J Higgins; Denise M Fox; Piotr S Kowalski; Jens E Nielsen; D Margaret Worrall
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

9.  Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus.

Authors:  Yury Kryvalap; Chi-Wen Lo; Ekaterina Manuylova; Raman Baldzizhar; Nicholas Jospe; Jan Czyzyk
Journal:  J Biol Chem       Date:  2015-11-17       Impact factor: 5.157

10.  Identification and characterization of a serine protease inhibitor of Paragonimus westermani.

Authors:  Jin-Hee Hwang; Wook-Gyo Lee; Byoung-Kuk Na; Hyeong-Woo Lee; Shin-Hyeong Cho; Tong-Soo Kim
Journal:  Parasitol Res       Date:  2008-10-17       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.